Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07288086

Reliability and Effectiveness of New Enova Preloaded Intaocular Lens and Cartridge System

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Istanbul University · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the safety and efficacy of the new Enova® preloaded monofocal intraocular lens and cartridge injector system in cataract surgery

Detailed description

In this prospective and single-center clinical study, the safety and efficacy of the Enova PGF3 intraocular lens (IOL) and cartridge injector system will be evaluated. The Enova PGF3 cartridge injector system is designed to be used in cataract surgeries. Cataract patients aged 40 years and older, both male and female, without any serious ocular disease other than cataracts, will undergo IOL implantation following cataract surgery. It is planned to perform a total of 200 implantations with either unilateral or bilateral implantation of the participants' eyes. Postoperative visual acuity, refraction, patient satisfaction, and adverse events will be monitored during follow-up visits at day 1, week 1, and month 1. The primary objectives of the study are to achieve an uncorrected distance visual acuity of 20/20 or better, and to maintain an error and complication rate related to the preloaded system below 7.5%. Secondary objectives include evaluating patient satisfaction and assessing whether surgeons find the preloaded system easy to use and if it meets their expectations. The primary endpoints are refractive stability within ±0.50 D, uncorrected distance visual acuity of 20/20 or better, and a general clinical performance rating of the preloaded system with a score of 95% or higher. Secondary endpoints include the duration of surgery, accuracy of lens positioning, surgical complications, surgeon-reported ease of use, and patient satisfaction survey results meeting expectations. As a safety parameter, adverse events reported in postoperative surgical reports will be evaluated.

Conditions

Interventions

TypeNameDescription
DEVICEPreloaded intraocular lens systemThis intervention uses a preloaded IOL delivery system, which allows for a single-use, sterile implantation during standard phacoemulsification cataract surgery. Unlike standard manually loaded IOLs, this system reduces preparation time and minimizes handling of the lens, potentially improving surgical efficiency and maintaining lens sterility.

Timeline

Start date
2025-05-10
Primary completion
2026-06-15
Completion
2026-07-11
First posted
2025-12-17
Last updated
2026-03-24

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07288086. Inclusion in this directory is not an endorsement.